Cargando…
Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia
Sickle cell disease (SCD) is a group of related yet genetically complex hemoglobinopathies. Universal newborn screening (NBS) for SCD is performed in the United States and many other nations. Classical, protein-based laboratory methods are often adequate for the diagnosis of SCD but have specific li...
Autores principales: | Shook, Lisa M., Haygood, Deidra, Quinn, Charles T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631351/ https://www.ncbi.nlm.nih.gov/pubmed/34859003 http://dx.doi.org/10.3389/fmed.2021.734305 |
Ejemplares similares
-
Clinical Utility of Confirmatory Genetic Testing to Differentiate Sickle Cell Trait from Sickle-β(+)-Thalassemia by Newborn Screening
por: Shook, Lisa M., et al.
Publicado: (2020) -
Implementation of a Process for Initial Transcranial Doppler Ultrasonography in Children With Sickle Cell Anemia
por: Crosby, Lori E., et al.
Publicado: (2016) -
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing
por: Zhou, Janet R., et al.
Publicado: (2021) -
A Paper-Based Test for Screening Newborns for Sickle Cell Disease
por: Piety, Nathaniel Z., et al.
Publicado: (2017) -
Microcytic Anemia: An Insidious Presentation of Sickle Cell Beta+ Thalassemia, a Rare Sickle Cell Variant
por: Shankar, Malavika, et al.
Publicado: (2022)